US Stocks
/
Relmada Therapeutics, Inc. Share Price
Relmada Therapeutics, Inc. Share Price

Relmada Therapeutics, Inc. Share Price

NASDAQ: RLMD | Micro Cap
$3.48
+$0.31 (9.95%) Last updated on 09 Oct, 2026 | 22:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Relmada Therapeutics, Inc. Stock Performance

Open
$3.16
Prev. Close
$3.17
Circuit Range
N/A
Day Range
$3.15 - $3.52
Year Range
$1.82 - $7.99
Volume
45,729
Average Traded
$3.39

Relmada Therapeutics, Inc. Share Price Today

As of 9 October 2026, Relmada Therapeutics, Inc.'s share price is $3.48. The stock opened at $3.16, compared to its previous close of $3.17. During today's trading session, Relmada Therapeutics, Inc.'s share price traded between $3.15 and $3.52, with an average price of $3.34. Over the past 52 weeks, the stock has recorded a high of $7.99 and a low of $1.82. In terms of performance, Relmada Therapeutics, Inc.'s share price has declined by 53.82% over the last six months and is up 56.76% on a year-on-year basis.

Relmada Therapeutics, Inc. Share Price Chart

$3.15$3.52
L
Show Current Price
H

Relmada Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$137.39M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.58
Revenue (TTM)
$0.00
Return On Equity (TTM)
-29.98%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-27.95%

Relmada Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.09-$19.87-$19.05-$12.91
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-96.93%4.13%32.23%

Relmada Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$157.04-$98.79-$79.98-$57.39
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A37.09%19.04%28.24%

About Relmada Therapeutics, Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Relmada Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.74
$3.48
-7.44%
Sep 2026
$4.34
$3.77
-16.70%
Aug 2026
$5.09
$4.52
-14.88%
Jul 2026
$6.83
$5.31
-23.38%
Jun 2026
$7.03
$6.93
-4.02%
May 2026
$7.61
$7.22
-4.18%
Apr 2026
$7.03
$7.54
+8.57%
Mar 2026
$4.71
$6.94
+53.20%
Feb 2026
$3.68
$4.53
+27.61%
Jan 2026
$4.75
$3.55
-26.42%
Dec 2025
$4.44
$4.83
+6.75%
Nov 2025
$2.19
$4.52
+103.60%

RLMD Share Price FAQs

What is Relmada Therapeutics, Inc. share price today?

chevron-up
Relmada Therapeutics, Inc. share price today is $3.48 as on October 9, 2026 at 10:15 pm IST.

What is the 52 week high and 52 week low of Relmada Therapeutics, Inc. stock?

chevron-up
The 52 week high of Relmada Therapeutics, Inc. stock is $7.99, while the 52 week low is $1.82 as of 9 Oct '26.

What is RLMD's market capitalisation today?

chevron-up
RLMD market capitalisation is $137.39M as of October 9, 2026, at 10:15 pm IST.

What is RLMD's net income for the last quarter?

chevron-up
RLMD's net income for the last quarter is -12.91B USD.

What is the 5 year returns of RLMD?

chevron-up
The 5 year returns of RLMD is -85.17% as on 9 Oct '26.

What is the high & low stock price of RLMD today?

chevron-up
RLMD stock price hit a high of $3.52 and low of $3.15 as of 9 Oct '26.

Can I buy RLMD shares in India?

chevron-up
Yes. You can buy RLMD in India by opening an international trading account.